As shown in Table 2, the RNA-Binding Motif Protein 39 (RBM39) splicing factor stimulates the inclusion of a cryptic exon containing a stop signal in the androgen receptor (AR) gene, giving rise to the oncogenic variant AR-V7, the best-characterised AR variant, in prostate cancer [50]. Here, RBM39 is linked to prostate carcinoma.